Dissolution variability unexplained during tech transfer – preventing late-stage reformulation


Published on 23/04/2026

Addressing Unexplained Dissolution Variability During Tech Transfer

Dissolution variability during tech transfer poses significant challenges for pharmaceutical companies, particularly when faced with late-stage reformulation. These variances can stem from numerous factors, leading to potential delays in regulatory submissions and product launches. By the end of this article, you will be equipped with a clear, actionable playbook to identify, analyze, and rectify dissolution inconsistencies efficiently, ensuring compliance with FDA, EMA, and ICH guidelines.

This playbook is tailored for professionals in manufacturing, quality control, quality assurance, engineering, and regulatory affairs, providing a structured approach to streamline the tech transfer process and mitigate risks associated with dissolution variability. Let’s delve into the actionable steps required to tackle this crucial issue effectively.

Symptoms/Signals on the Floor or in the Lab

The detection of dissolution variability typically arises from both quantitative data and qualitative observations in the lab or manufacturing floor. Here are the common signals:

  • Inconsistent Dissolution Profiles: Variability across batches when analyzing dissolution results can indicate
underlying issues.
  • Increased Batch Discrepancies: Larger deviations from expected dissolution rates in comparative studies signal potential formulation or process inconsistencies.
  • Quality Control Alerts: Frequent flags in quality control testing metrics can be symptoms of instability or variability in formulation.
  • Feedback from Regulatory Audits: Non-conformities cited during regulatory inspections regarding dissolution criteria can highlight issues in tech transfer.
  • Likely Causes

    To effectively address dissolution variability, it’s crucial to understand its potential causes, categorized as follows:

    1. Materials

    • Raw material quality variation
    • Differences in excipient performance across suppliers

    2. Method

    • Inadequate dissolution methodology
    • Variability in dissolution apparatus calibration

    3. Machine

    • Equipment malfunctions impacting dissolution testing
    • Variability in environmental controls during process operations

    4. Man

    • Operator errors during dissolution testing
    • Inconsistent SOP adherence

    5. Measurement

    • Inaccurate analytical techniques
    • Variability caused by instrument calibration

    6. Environment

    • Fluctuations in temperature and humidity during the manufacturing process
    • Contamination from external sources

    Immediate Containment Actions (first 60 minutes)

    When dissolution variability is identified, swift containment is necessary. Here’s a prompt action checklist:

    • Stop Production: Halt any ongoing manufacturing runs to prevent further discrepancies.
    • Isolate Affected Batches: Quarantine all materials or batches implicated in the dissolution failure.
    • Review Testing Procedures: Reassess the dissolution testing setup and methodology for immediate anomalies.
    • Communicate with Stakeholders: Inform manufacturing, QA, and RA teams about the issue for coordinated response efforts.
    • Begin Documentation: Log initial findings and steps taken to ensure inspection readiness.

    Investigation Workflow (data to collect + how to interpret)

    A structured investigation is essential for root cause analysis of dissolution variability. Follow these steps:

    1. Data Collection: Gather comprehensive data, including:
      • Dissolution profiles from different batches
      • Process parameters during manufacturing
      • Raw materials and suppliers’ certificates of analysis (CoA)
      • Calibration records of dissolution equipment
      • Operator logs and SOP adherence records
    2. Data Segregation: Categorize data based on factors: materials, methods, machines, operators, and environment.
    3. Trend Analysis: Use statistical software to trend dissolution results versus production variables.
    4. Data Visualization: Create graphs to easily compare batches and identify outliers.
    5. Preliminary Conclusions: Draw initial conclusions regarding impacting variables before conducting a detailed root cause analysis.

    Root Cause Tools (5-Why, Fishbone, Fault Tree, and when to use which)

    Understanding the root cause of dissolution variability requires systematic analysis using various tools:

    1. 5-Why Analysis

    Best used for simple problems, this tool asks “why” repeatedly (typically five times) to drill down to the underlying issue.

    2. Fishbone Diagram (Ishikawa)

    Ideal for more complex issues, this diagram helps categorize potential causes by factors such as method, machine, and man.

    3. Fault Tree Analysis

    Uses a top-down approach for more systemic connections. It’s useful for understanding how various factors interact and contribute to the problem.

    Choose the appropriate tool based on the complexity of the situation and available data, ensuring effective root cause identification.

    CAPA Strategy (correction, corrective action, preventive action)

    A robust CAPA strategy involves:

    Related Reads

    1. Correction:

    • Immediate fixes to resolve the dissolution variability for affected batches.
    • Validation of corrective actions taken and their effectiveness.

    2. Corrective Action:

    • Identify and address the root causes, revising SOPs and training if necessary.
    • Conduct risk assessment regarding formulation and process parameters.

    3. Preventive Action:

    • Implement a monitoring plan to detect early signs of variability in future batches.
    • Enhance supplier quality management to reduce material variability.

    Control Strategy & Monitoring (SPC/trending, sampling, alarms, verification)

    After implementing corrective actions, it’s crucial to establish effective monitoring and control measures:

    • Statistical Process Control (SPC): Use SPC to track dissolution profiles and detect variability trends over time.
    • Sampling Plans: Implement a sampling plan that includes using a statistically valid number of samples.
    • Set Alarm Thresholds: Configure alarms for real-time monitoring of critical parameters to mitigate risks promptly.
    • Verification: Regularly verify analytical methods and equipment calibration to ensure compliance and accuracy.

    Validation / Re-qualification / Change Control impact (when needed)

    Acknowledge that any change as part of the CAPA strategy may necessitate validation or re-qualification:

    • Review the impact of changes on existing validation documentation.
    • Conduct formal change control processes for any alterations in materials, methods, or equipment.
    • Re-validate dissolution testing methods in case of fundamental shifts in formulation or process.

    Inspection Readiness: What Evidence to Show

    Maintain thorough documentation to ensure inspection readiness during audits:

    • Accurate Records: Keep accurate records of dissolution tests, analytical results, and all investigations.
    • Logs: Document all quality control measures and CAPA actions taken, providing evidence of compliance.
    • Batch Documentation: Ensure that batch records include details of any deviations and their resolutions.
    • Deviation Reports: Prepare clear, concise deviation reports explaining any inconsistencies during dissolution testing.

    FAQs

    What is dissolution variability?

    Dissolution variability refers to inconsistencies in the rate or extent to which active pharmaceutical ingredients dissolve in a specified medium, impacting drug performance.

    How can I identify if dissolution variability is affecting my product?

    Monitor dissolution testing results closely. Significant discrepancies in batch profiles are immediate indicators of potential variability.

    What are typical causes of dissolution variability?

    Causes range from raw material inconsistencies, procedural errors, equipment calibration failures, to environmental factors.

    What role does statistical analysis play in addressing variability?

    Statistical analysis can help identify trends and outliers in dissolution data, aiding in the identification of root causes.

    Why is immediate containment crucial?

    Immediate containment helps prevent further production of potentially non-compliant batches, minimizing waste and rework.

    What is the difference between correction and corrective action in CAPA?

    Correction refers to fixing immediate issues, while corrective action addresses the root cause to prevent recurrence.

    Can dissolution variability affect regulatory approval?

    Yes, inconsistencies can lead to non-conformities during audits, potentially delaying approval processes.

    How often should we revisit our dissolution testing methods?

    Regular reviews are recommended, particularly after significant changes in formulation, manufacturing environments, or processes.

    Pharma Tip:  Prototype not scalable during IND/NDA filing – preventing late-stage reformulation